Balchem BCPC Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Animal Nutrition and Health | $230.85M+7.5% | $214.71M-9.9% | $238.33M-9.1% | $262.3M+15.7% | |
| Human Nutrition and Health | $659.39M+9.9% | $600.26M+9.0% | $550.75M+4.5% | $527.13M+19.1% | |
| Specialty Products | $140.98M+6.2% | $132.75M+5.4% | $125.97M-4.2% | $131.44M+12.3% | |
| Operating Income (Loss) by Business | |||||
| Animal Nutrition and Health | $18.69M+33.4% | $14.01M-49.2% | $27.58M-23.5% | $36.06M— | |
| Human Nutrition and Health | $153.91M+13.2% | $135.96M+32.7% | $102.42M+24.7% | $82.13M— | |
| Specialty Products | $42.9M+7.5% | $39.91M+15.4% | $34.58M+5.5% | $32.79M— | |
| Gross Profit by Business | |||||
| Animal Nutrition and Health | $50.56M+16.8% | $43.3M-20.5% | $54.5M-12.2% | $62.05M— | |
| Human Nutrition and Health | $244.29M+10.1% | $221.85M+20.4% | $184.21M+19.6% | $154.07M— | |
| Specialty Products | $77.37M+5.5% | $73.3M+14.9% | $63.78M+4.4% | $61.1M— | |
| Operating expenses by Business | |||||
| Animal Nutrition and Health | $31.87M+8.8% | $29.29M+8.8% | $26.92M+3.6% | $25.99M— | |
| Human Nutrition and Health | $90.38M+5.2% | $85.89M+5.0% | $81.79M+13.7% | $71.94M— | |
| Specialty Products | $34.46M+3.2% | $33.4M+14.4% | $29.2M+3.2% | $28.31M— | |
| Total Assets by Business | |||||
| Animal Nutrition and Health | $691.11M+9.5% | $630.97M-7.5% | $681.77M-3.0% | $702.86M+12.5% | |
| Human Nutrition and Health | $4.94B+4.4% | $4.73B+0.3% | $4.71B+11.2% | $4.24B+45.9% | |
| Specialty Products | $685.52M+3.6% | $661.66M-4.2% | $690.5M-2.5% | $708.21M-5.0% | |
| Cost of Sales by Business | |||||
| Animal Nutrition and Health | $180.29M+5.2% | $171.41M-6.8% | $183.83M-8.2% | $200.25M— | |
| Human Nutrition and Health | $415.1M+9.7% | $378.41M+3.2% | $366.54M-1.7% | $373.06M— | |
| Specialty Products | $63.61M+7.0% | $59.45M-4.4% | $62.18M-11.6% | $70.34M— | |
| D&A by Business | |||||
| Animal Nutrition and Health | $7.28M-11.6% | $8.23M+4.5% | $7.88M+17.8% | $6.69M-9.8% | |
| Human Nutrition and Health | $30.12M-4.9% | $31.67M-17.9% | $38.57M+14.4% | $33.73M+12.4% | |
| Specialty Products | $7.37M+4.6% | $7.04M-3.2% | $7.28M-3.1% | $7.51M-9.9% | |
| Goodwill, Acquired During Period by Business | |||||
| Animal Nutrition and Health | $0— | $0— | —— | —— | |
| Human Nutrition and Health | $823K-95.8% | $19.38M— | —— | —— | |
| Specialty Products | $0— | $0— | —— | —— | |
| CapEx by Business | |||||
| Animal Nutrition and Health | $16.83M+27.5% | $13.2M+88.8% | $6.99M-35.3% | $10.81M+33.4% | |
| Human Nutrition and Health | $21.22M+20.8% | $17.57M-33.5% | $26.42M-21.5% | $33.67M+42.0% | |
| Specialty Products | $4.63M+14.3% | $4.05M+14.6% | $3.54M-11.7% | $4M+5.3% | |
| Net Sales by Product | |||||
| Product Sales Revenue | $1.04B+8.8% | $951.95M+3.5% | $919.95M-2.0% | $939.17M+18.2% | |
| Royalty Revenue | $1.89M+8.8% | $1.74M-30.2% | $2.49M-22.1% | $3.19M-29.1% | |
| Cost of Sales by Product | |||||
| Raw materials sold | $39.48M+32.5% | $29.8M-12.9% | $34.22M— | —— | |
| Services provided | $4.64M+4.9% | $4.43M+1.4% | $4.36M— | —— | |
| Net Sales by Geography | |||||
| Non-US | $277.71M+20.5% | $230.38M-1.1% | $232.84M-10.5% | $260.12M+21.3% | |
| United States | $759.45M+5.0% | $723.3M+4.9% | $689.6M+1.1% | $682.24M+16.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Balchem break its business down?
- Balchem (BCPC) reports net sales by business across 3 parts — Animal Nutrition and Health, Human Nutrition and Health and Specialty Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Balchem's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Balchem's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
